Himalaya Nutravedics India (SME IPO)
📅 Dates: 22 - 24 Sep • 💰 Issue Size: 24,99,600 shares (agg. up to ₹26 Cr)Complete guide to Himalaya Nutravedics India SME IPO: latest Grey Market Premium (GMP), live bidding subscription status, price band, lot size, financial report, and investment analysis.
📊 Overview & Key Highlights
| Parameter | Details |
|---|---|
| Issue Type | SME IPO (SME) |
| Issue Dates | 22 - 24 Sep |
| Price Band | ₹100 to ₹106 |
| Total Issue Size | 24,99,600 shares (agg. up to ₹26 Cr) |
| Minimum Market Lot | 1200 shares |
| Listing Price (Debut) | ₹128.35 (-₹6.75 (-5.00%)) |
| Subscription Status | 2.33x (Final / Bidding Closed) |
| Investor Demand Rating | ⭐⭐⭐☆☆ (3/5 - Moderate Demand) |
🎯 Investment Analysis & Verdict
📌 Business Model & Revenue Streams
Himalaya Nutravedics makes its money by manufacturing and marketing Ayurvedic and nutraceutical healthcare products, alongside taking on third-party contract manufacturing gigs. Instead of spending heavily on mass consumer advertising, they push their branded therapeutics directly through doctors and healthcare practitioners who recommend them to patients.🚀 Key Strengths & Growth Drivers
• Certified manufacturing muscle: Their Hyderabad facility holds WHO-GMP and ISO certifications, which makes them a reliable, compliant partner for third-party contract manufacturing.• Practitioner-led distribution: Bypassing expensive retail shelf wars and mass TV ads by targeting doctors directly keeps customer acquisition costs more grounded.
• Pan-India footprint: Operations already span 17 states and a union territory, giving them a ready distribution network to scale new formulations without starting from scratch.
⚠️ Key Risks & Red Flags
• SME liquidity constraints: At a 24.96 lakh share issue size, trading volumes post-listing will likely be thin, making it tough to exit quickly if market sentiment turns sour.• Contract manufacturing vulnerability: Relying on third-party production means margins can get squeezed easily if raw material prices for herbs and chemicals spike.
• Intense competition: The Ayurvedic and wellness space is heavily crowded with both nimble D2C brands and entrenched FMCG giants fighting for doctor recommendations.
🎯 Retail Verdict
This SME IPO is a micro-cap bet that lacks the liquidity needed for safe, hassle-free exits. Given the typical volatility in the SME segment, retail investors should exercise extreme caution and wait to see how the stock behaves post-listing rather than rushing in for a quick listing pop.📅 Tentative Timetable
| Event | Tentative Date |
|---|---|
| IPO Open | Tue, Sep 22, 2026 |
| IPO Close | Thu, Sep 24, 2026 |
| Allotment | Fri, Sep 25, 2026 |
| Refund | Mon, Sep 28, 2026 |
| Credit of Shares | Mon, Sep 28, 2026 |
| Listing | Tue, Sep 29, 2026 |
📈 Live Subscription Demand
| Category | Subscription Multiplier (x) |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non-Institutional / HNI | 3.58x |
| Retail Individual (RII) | 2.56x |
| Total Subscription | 2.33x (Updated: 07 Oct, 17:43) |
💼 Market Lot & Investment Sizing
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 2400 | ₹2,54,400 |
| Individual investors (IND) (Max) | 2 | 2400 | ₹2,54,400 |
| S-HNI (Min) | 3 | 3600 | ₹3,81,600 |
| S-HNI (Max) | 7 | 8400 | ₹8,90,400 |
| B-HNI (Min) | 8 | 9600 | ₹10,17,600 |
💰 Financial Summary
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 24.42 | 10.82 | 6.09 |
| Total Income | 43.12 | 21.00 | 14.43 |
| Profit After Tax | 7.39 | 2.23 | 0.43 |
| EBITDA | 8.10 | 2.99 | 0.94 |
| NET Worth | 16.38 | 6.75 | 1.34 |
| Reserves and Surplus | 10.07 | 2.76 | 0.53 |
| Total Borrowing | 5.13 | 1.76 | 3.24 |
| Amount in ₹ Crore |
🏢 About Himalaya Nutravedics India
Himalaya Nutravedics India is a specialized health and wellness company engaged in the marketing of branded healthcare products and third-party contract manufacturing. The company offers a broad therapeutic portfolio spanning Ayurvedic and nutraceutical segments, distributing its products through healthcare practitioners rather than relying on mass advertising. Backed by a WHO-GMP, ISO 22000:2018, and ISO 9001:2015 certified manufacturing facility located in Hyderabad, Telangana, the company has established a commercial presence across 17 states and one union territory in India with a dedicated workforce.💬 Community Discussion & Views
Are you planning to apply for the Himalaya Nutravedics India IPO? Share your bidding strategy, allotment status, or listing expectations with fellow investors in the replies below!👉 Browse all upcoming Mainboard & SME IPOs on UNP
Disclaimer: All IPO details provided above are for educational and informational purposes only. Readers are advised to consult their financial advisors and review the Red Herring Prospectus (RHP) before investing.
📌 Thread Quick Navigation: Post #2: Live & Historic GMP | Post #3: Subscription Stats | Post #4: Allotment Status | Post #5: Listing Debut | Post #6: Community & Social Reviews
Last edited: